| Bioactivity | Indanazoline (as monohydrochloride active substance of Farial) is characterized by a pronounced vasoconstrictive action. |
| In Vivo | In animal experiments the new imidazoline derivative indanazoline (as monohydrochloride active substance of Farial) is characterized by a pronounced vasoconstrictive action after local or intravenous application[1]. |
| Name | Indanazoline |
| CAS | 40507-78-6 |
| Formula | C12H15N3 |
| Molar Mass | 201.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kretzschmar R, et al. [Pharmacology of N-(2-imidazolin-2-yl)-N-(4-indanyl)amino (indanazoline), a new vasoconstrictive imidazoline compound]. Arzneimittelforschung. 1980;30(10):1746-60. |
Indanazoline
CAS: 40507-78-6 F: C12H15N3 W: 201.27
Indanazoline (as monohydrochloride active substance of Farial) is characterized by a pronounced vasoconstrictive action.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.